SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Filana Therapeutics, Inc. (FLNA) News

Follow Filana Therapeutics, Inc. (FLNA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol FLNA Asset equity Sector Markets 90 days 5 Last 0.6398 Updated Nov 18, 2026, 09:07 PM UTC Open live news feed Open FLNA chart & news
M Filana Therapeutics Officer Acquires Shares Worth $55,924.50 EQUITY | Nov 18, 2026, 09:07 PM UTC L Filana Therapeutics 3Q 2026: EPS ($0.22) — 10-Q Summary Filana Therapeutics reported a narrower quarterly net loss year over year, as lower research and development and general and administrative expenses more than offset reduced interest income. The company has not generated EARNINGS | Nov 05, 2026, 09:18 PM UTC M Filana Therapeutics Reports Q3 2026 Results and Business Update The company said patient screening in its Phase 2a study of simufilam in TSC-related epilepsy is expected to begin by Q1 2. EQUITY | Nov 05, 2026, 01:15 PM UTC M FDA lifts clinical hold on Filana’s simufilam for TSC-related epilepsy TradingView News reports the FDA lifted the clinical hold on Filana’s simufilam for TSC-related epilepsy. EQUITY | Sep 22, 2026, 12:45 PM UTC M FDA lifts clinical hold on simufilam IND; Phase 2a in TSC epilepsy Filana Therapeutics said the FDA lifted the clinical hold on its IND for simufilam, enabling a planned Phase 2a study in TSC-related epilepsy, with screening expected to begin by Q1 2027. REGULATION | Sep 22, 2026, 12:04 PM UTC L FLNA - Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? FLNA - Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? EQUITY | Aug 12, 2026, 06:21 PM UTC L FLNA - Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update FLNA - Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update EARNINGS | Jul 29, 2026, 12:00 PM UTC